Cypress, Texas
Alzheimer's disease clinical trials in Cypress, TX
8 Alzheimer's disease studies are recruiting participants at sites in Cypress as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Cypress at a glance
- 8 studies are recruiting at a site in Cypress.
- By phase: Phase 2 (3), Phase 2/3 (1), Phase 3 (4).
- By sponsor: industry (8).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Cypress
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Horizon Clinical Research: Gill Neuroscience
- Registry record
- NCT05980949 · updated
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Horizon Clinical Research Center - Houston
- Registry record
- NCT06937229 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study site
- Horizon Clinical Research Group
- Registry record
- NCT06159673 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Horizon Clinical Research Group
- Registry record
- NCT06540833 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Horizon Clinical Research Center - Houston
- Registry record
- NCT07011745 · updated
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Horizon Clinical Research Center - Houston ( Site 1026)
- Registry record
- NCT07033494 · updated
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Registry record
- NCT06126224 · updated
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- Celgene
- Study site
- Horizon Clinical Research Center - Houston
- Registry record
- NCT06808984 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Cypress, TX on ClinicalTrials.gov.
Ask about studies near Cypress
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
47 studies recruiting across 23 cities.
Houston
14 studies recruiting.
Austin
11 studies recruiting.
Dallas
11 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections